London Cartilage Clinic
Explore expert articles on cartilage care, regenerative treatments, and practical recovery advice from our specialist team.
In appropriately selected patients, knee osteotomy delays total knee replacement by 10 to 15 years by realigning the leg to redirect body weight away from worn cartilage.
ChondroFiller, a collagen scaffold injected under ultrasound, replaces knee surgery for focal cartilage lesions by recruiting the body's own repair cells, delivering sustained relief to 70–85% of treated patients without hospital admission or post-operative recovery.
Two patients with identical knee MRI findings can experience markedly different pain levels; determining which structural change is actually causing symptoms requires clinical assessment, not the report alone.
Osteochondral allograft replaces both cartilage and underlying bone, making it the primary choice for large knee defects where cartilage-only procedures like MACI cannot address bone damage.
Physiotherapy resolves talar cartilage lesions in roughly half of cases. For those with persistent pain, ChondroFiller—an injectable collagen scaffold—provides a third option: a physical framework that the body's own repair cells colonise and gradually replace with new cartilage over one to two years.
ChondroFiller injection has produced no serious adverse effects across 19,000+ clinical cases since 2013; the complaint rate stands at 0.06%, among the lowest in cartilage repair. Post-injection swelling, pain, and stiffness resolve within 48–72 hours, but follow-up data beyond three years remain sparse.
